The new “Recreational Europe” report reveals an overwhelming public opinion in Europe in support of cannabis legalisation.
2021 saw countries in Europe such as Germany and Denmark discuss moves towards progressive cannabis policy. As these developments unfold, the new report takes a deep look at European consumer and regulatory attitudes toward adult-use cannabis legalisation in the continent’s burgeoning cannabis market.
Conducted by Hanway Associates in partnership with Curaleaf International, Cansativa and international law firm Ince, the report makes the case that now is the time to invest in the European cannabis marketplace.
Public opinion
Polling data from the report across eight European markets found that 55 per cent of Europeans support adult-use cannabis legalisation.
Founder of The Hanway Company, Alastair Moore, commented: “We produced this report to cut through the noise around cannabis legalisation in Europe.
Read more: Copenhagen proposes five year pilot of recreational cannabis
“The topic, which was once characterised by extremely polarized voices for and against legalisation, is quickly becoming a more tame, bureaucratic conversation around civic priorities. Public opinion across Europe is now clearly in favour of legalising cannabis and governments across the continent are already creating legal access programmes. What was once a hypothetical scenario is fast becoming a reality.”
The report also found that 30 per cent of Europeans are interested in trying cannabis, a majority support regulated cannabis shops but do not support growing at home and top concerns among Europeans are youth cannabis use and increased driving under the influence of cannabis. However, social equity is not yet a core priority for Europeans
Legal challenges
The report highlights that legal framework of cannabis legalisation is not just a matter of domestic legislation, as there are other legal considerations such as UN Drug Control Treaties and EU acquis to include.
This presents legal challenges and possible blockers to commercial cannabis legalisation which will impact international exports of recreational cannabis and other cannabis-related trade.
It also highlights that companies looking to maximise the emerging opportunities in the cannabis market in Europe have complex legal challenges to consider, including the impact that legalisation will have on the Proceeds of Crime Act and associated implications, as well as compliance with other anti-money laundering (AML) regulations.
As legalisation scales, it is anticipated that so will the drive for companies to raise capital, list on public markets, and access other financial markets and crucial ancillary services such as banking and insurance.
The legal sector will play a key role in assisting and advising companies to successfully navigate these challenges as they increase fundraising, IPOs, and M&A activity. Other major opportunities for the legal sector exist in compliance and in aiding cannabis operators to license applications.
Boris Jordan, executive chairman of US-based Curaleaf, commented: “We see the European market as three to four years behind, but it actually looks like Europe may initiate sweeping reform before the United States.
“Germany indicating they will legalise recreational use will be an inflection point for the market since it represents the largest economy in Europe, and we feel once Germany goes the rest of the continent will follow suit.”
In addition to the report’s findings around commercial and societal support for legalisation, European regulators have signaled that they are open to loosening cannabis restrictions
“In France, the political leaders remain anchored in an untenable position,” said Ludovic Mendes, MP for the second constituency of Moselle for the LREM group, member of the law commission.
“We need to have a society-based debate because this is not solely a political issue, it is a societal one. There is a need to work with scientists, doctors, pharmacists, and addiction experts to break down the stereotypes regarding cannabis consumption.
“Speech of utter repression is no longer an option. I, therefore, appeal for a great national debate with referendum consultations to be put in place immediately after the presidential election.”
Matthew Stratton, Partner at Ince, added: “Recreational Europe collects some fascinating insights into the cannabis market in Europe and we are delighted to have contributed to this report.
“The particularities of this sector – including the level of associated risk due to market maturity, political connotations, and social implications – imply greater need for companies to seek specialist corporate legal advisors to support them through IPOs, M&As and other transactions, as well as tackle any AML compliance issues that may arise.
“We have noticed growing interest in European-based cannabis companies – especially from North American organisations looking for acquisition targets on the continent. We expect a highly rewarding landscape and a prosperous future ahead for the cannabis sector as the European public positively shifts its views about cannabis and facilitates a regulatory shift in the region towards legalisation.”
[activecampaign form=31]
- European Medicines Agency gives cannabinoid medicine positive opinion
- Curaleaf International on the growth of the European cannabis market
- Review to establish greater strategic coherence for UK legal cannabis
- German cannabis legalisation in sight following coalition agreement
- Kanabo becomes second cannabis company to list on the LSE